NASDAQ:DUSA - Davis Select U.S. Equity ETF Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$22.2891 +0.24 (+1.08 %)
(As of 02/19/2019 06:30 AM ET)
Previous Close$22.05
Today's Range$22.15 - $22.2891
52-Week Range$18.76 - $26.54
Volume7,836 shs
Average Volume25,521 shs
Market Capitalization$177.20 million
P/E RatioN/A
Dividend Yield0.84%
BetaN/A
DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company's marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp. During the year ended December 31, 2011, it initiated an exploratory DUSA-sponsored clinical trial designed to study the broad area application and/or short drug incubation (BASDI), method of using the Levulan Kerastick, which is being carried out at 10 clinical trial sites. DUSA manufactures its Levulan Kerastick in its Wilmington, Massachusetts facility. Its wholly owned subsidiaries include DUSA Pharmaceuticals New York, Inc. and Sirius Laboratories, Inc. As of December 31, 2011, DUSA ceased marketing and selling its remaining Non-PDT products, which were ClindaReach and Meted.

Receive DUSA News and Ratings via Email

Sign-up to receive the latest news and ratings for DUSA and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Davis Advisors
Fund NameDavis Select U.S. Equity ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:DUSA
Inception Date1/11/2017
Fund ManagerChristopher Davis, Danton Goei
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNot Applicable
CategorySize and Style
FocusLarge Cap
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$105.87 million
Average Daily Volume$18,645.00
Discount/Premium0.40%

ETF Expenses

Management Fee0.55%
Other Expenses0.26%
Total Expenses0.81%
Fee Waiver-0.16%
Net Expenses0.65%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorDavis Selected Advisers, L.P.
CustodianState Street Bank and Trust Company
DistributorForeside Fund Services, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of Davis Select U.S. Equity ETF (NASDAQ:DUSA)
Currency Exposure of Davis Select U.S. Equity ETF (NASDAQ:DUSA)
Sector Exposure of Davis Select U.S. Equity ETF (NASDAQ:DUSA)
Industry Exposure of Davis Select U.S. Equity ETF (NASDAQ:DUSA)

Davis Select U.S. Equity ETF (NASDAQ:DUSA) Frequently Asked Questions

What is Davis Select U.S. Equity ETF's stock symbol?

Davis Select U.S. Equity ETF trades on the NASDAQ under the ticker symbol "DUSA."

How often does Davis Select U.S. Equity ETF pay dividends? What is the dividend yield for Davis Select U.S. Equity ETF?

Davis Select U.S. Equity ETF announced an annual dividend on Wednesday, December 26th. Investors of record on Thursday, December 27th will be given a dividend of $0.5544 per share on Friday, December 28th. This represents a dividend yield of 2.83%. The ex-dividend date is Wednesday, December 26th. View Davis Select U.S. Equity ETF's Dividend History.

Has Davis Select U.S. Equity ETF been receiving favorable news coverage?

Press coverage about DUSA stock has trended very positive recently, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Davis Select U.S. Equity ETF earned a news impact score of 3.3 on InfoTrie's scale. They also assigned news articles about the healthcare company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future.

Who are Davis Select U.S. Equity ETF's major shareholders?

Davis Select U.S. Equity ETF's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Level Four Advisory Services LLC (2.62%), LPL Financial LLC (1.01%), D.A. Davidson & CO. (1.01%), IFP Advisors Inc (0.58%), Raymond James Financial Services Advisors Inc. (0.51%) and Raymond James & Associates (0.47%).

Which institutional investors are selling Davis Select U.S. Equity ETF stock?

DUSA stock was sold by a variety of institutional investors in the last quarter, including Level Four Advisory Services LLC, LPL Financial LLC, IFP Advisors Inc and Diligent Investors LLC.

Which institutional investors are buying Davis Select U.S. Equity ETF stock?

DUSA stock was bought by a variety of institutional investors in the last quarter, including Raymond James & Associates, D.A. Davidson & CO., Raymond James Financial Services Advisors Inc., Financial Advocates Investment Management, Benjamin F. Edwards & Company Inc. and Stratos Wealth Partners LTD..

How do I buy shares of Davis Select U.S. Equity ETF?

Shares of DUSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Davis Select U.S. Equity ETF's stock price today?

One share of DUSA stock can currently be purchased for approximately $22.2891.

How big of a company is Davis Select U.S. Equity ETF?

Davis Select U.S. Equity ETF has a market capitalization of $177.20 million.


MarketBeat Community Rating for Davis Select U.S. Equity ETF (NASDAQ DUSA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  67 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  147
MarketBeat's community ratings are surveys of what our community members think about Davis Select U.S. Equity ETF and other stocks. Vote "Outperform" if you believe DUSA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DUSA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Featured Article: Preferred Stock

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel